Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2022 Sep 6:13:994469.
doi: 10.3389/fphys.2022.994469. eCollection 2022.

Hypoxia-related mechanisms inducing acute mountain sickness and migraine

Affiliations
Review

Hypoxia-related mechanisms inducing acute mountain sickness and migraine

Florian Frank et al. Front Physiol. .

Abstract

Experimental models of human diseases are vital for pathophysiological and therapeutic research. To investigate the initiation, maintenance, pathophysiology and even termination of a migraine/headache attack these models are urgently needed. Results from different studies promote the profound involvement of hypoxia in migraine and other primary/secondary headaches. The possible mechanisms that drive the induction of headaches through hypoxia are still unknown, but several modes of action, such as increased blood flow, dilation of cerebral arteries, the release of nitroglycerin, calcitonin gene-related peptide and adenosine or increased oxygen extraction are discussed intensively. In studies exposing healthy volunteers and people with a history of migraine to controlled normobaric hypoxia, our research group could demonstrate normobaric hypoxia to be an effective trigger of migraine headaches. Furthermore, a longitudinal measurement of calcitonin gene-related peptide (CGRP), during a hypoxic challenge in migraine patients, revealed increasing CGRP levels with prolonged hypoxic challenge. Since GRP has been linked to migraine and other headache disorders, hypoxia could be regarded as initiator for headaches on a neurotransmitter basis. Furthermore, it has been known for more than 2 decades from studies in vitro and in vivo that hypoxia can induce cortical spreading depression, a phenomenon believed to represent aura. Considering the increased prevalence of migraine in altitude populations and the solid pathophysiological changes on cellular and neurotransmitter level-the role of hypoxia should be investigated in greater detail by the headache community.

Keywords: AMS; CGRP; HAH; human migraine model; hypoxia; migraine.

PubMed Disclaimer

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Figures

FIGURE 1
FIGURE 1
Potential mechanism of hypoxia-induced cortical spreading depression (CSD) in migraine. Normobaric hypoxia can cause activation of redox-sensitive transient receptor potential channels (TRP) with further insertion of transmembrane proteins involved in signal propagation. Trigeminal afferents become sensitized via meningeal nociceptors inducing higher activity in central projections promoting cortical excitation leading to CSD. The initial wave of depolarization followed by tissue hypoxemia results in further activation and sensitization of pain processing pathways and thus migraine pain. Adapted from (Frank et al., 2020).

Similar articles

Cited by

References

    1. Alpuente A., Gallardo V. J., Asskour L., Caronna E., Torres-Ferrus M., Pozo-Rosich P. (2022). Salivary CGRP can monitor the different migraine phases: CGRP (in)dependent attacks. Cephalalgia. 42 (3), 186–196. 10.1177/03331024211040467 - DOI - PubMed
    1. Amery W. K. (1982). Brain hypoxia: The turning-point in the Genesis of the migraine attack? Cephalalgia 2 (2), 83–109. 10.1046/j.1468-2982.1982.0202083.x - DOI - PubMed
    1. Amery W. K. (1985). Migraine and cerebral hypoxia: A hypothesis with pharmacotherapeutic implications. Cephalalgia. 5, 131–133. 10.1177/03331024850050S224 - DOI - PubMed
    1. Arngrim N., Schytz H. W., Britze J., Amin F. M., Vestergaard M. B., Hougaard A., et al. (2016). Migraine induced by hypoxia: An MRI spectroscopy and angiography study. Brain 139, 723–737. 10.1093/brain/awv359 - DOI - PubMed
    1. Ashina M., Doležil D., Bonner J. H., Zhou L., Klatt J., Picard H., et al. (2021a). A phase 2, randomized, double-blind, placebo-controlled trial of AMG 301, a pituitary adenylate cyclase-activating polypeptide PAC1 receptor monoclonal antibody for migraine prevention. Cephalalgia. 41 (1), 33–44. 10.1177/0333102420970889 - DOI - PMC - PubMed